Press releases

2015-12-07 - Stallergenes SAS is proceeding with a recall of allergy immunotherapy products

2015-12-02 - Stallergenes Greer announces a temporary suspension of manufacturing at its Stallergenes SAS Antony plant

2015-11-19 - Stallergenes Greer announces the launch of ActairⓇ in Japan

2015-11-10 - Stallergenes Greer appoints Michele Antonelli as Executive Vice President, Head of International Operations

2015-11-06 - Introducing a new global allergy company

2015-10-27 - Ares Allergy Holdings PLC becomes Stallergenes Greer PLC

2015-10-23 - Updates on the development of its house dust mite sublingual immunotherapy tablet in allergic asthma

2015-10-14 - Ares Allergy Holding PLC to hold business update on 5 November 2015 and announces financial reporting schedule

2015-09-30 - Ares Allergy Holding PLC publishes Hal-Year 2015 Report and Financial Statements

2015-09-21 - Notice of extraordinary general assembly on 27 October 2015

2015-09-08 - Announcement: creation of the global leader in allergy immunotherapy

2015-09-03 - Announcement: Ares Allergy Holdings plc has secured AMF approval of its prospectus for listing its shares on Euronext Paris

2015-08-31 - Announcement: end of the liquidity contract for Stallergenes shares

2015-07-22 - Half-Year Revenues and Results

2015-07-21 - Announcement: the new board of Ares Allergy appoints Fereydoun Firouz Chairman and CEO

2015-06-26 - Announcement: Stallergenes shareholders approve the project to combine the activities of the group and Greer Laboratories

2015-05-27 - Announcement: information document available as of today

2015-05-20 - Announcement of availability of draft merger agreement and reports from court appointed expert Ledouble

2015-05-13 - Announcement: availability of the report by Ricol Lasteyrie Corporate Finance

2015-05-12 - Approval of the final terms of the project by Stallergenes' Board of Directors

2015-04-21 - Strong sales growth in Q1 2015 (up 7.5%) Exceeding targets

2015-04-15 - Assessment of the proposed combination of Stallergenes and Greer Laboratories has begun

2015-03-30 - Approval in Japan of STG 320

2015-03-26 - Update on the project to combine Stallergenes and Greer Laboratories

2015-03-03 - 2,5% growth in net sales. EBITDA outperformed 2014 targets

2015-03-03 - Project to combine Stallergenes and Greer Laboratories submitted to the board of the company